From: Causal relationship analysis of MRI measurements of major human internal organs and liver disease
Exposure/outcome | Abbreviation | Definition | GWASID | Sample size | Year of publication |
---|---|---|---|---|---|
Liver volume | LV | The MRI protocol (imaging-derived phenotypes, IDPs) of the UKBB | GCST90016666 | 32,860 | 2021 |
Pancreas iron | PI | Same as above | GCST90016676 | 32,860 | 2021 |
Kidney volume | KV | Same as above | GCST90016670 | 32,860 | 2021 |
Liver fat | LF | Same as above | GCST90016673 | 32,860 | 2021 |
Liver iron | LI | Same as above | GCST90016674 | 32,860 | 2021 |
Lung volume | LUV | Same as above | GCST90016668 | 32,860 | 2021 |
Pancreas fat | PF | Same as above | GCST90016675 | 32,860 | 2021 |
Pancreas volume | PV | Same as above | GCST90016669 | 32,860 | 2021 |
Spleen volume | SV | Same as above | GCST90016667 | 32,860 | 2021 |
Subcutaneous adipose tissue measurement | SATM | Same as above | GCST90016672 | 32,860 | 2021 |
Visceral adipose tissue measurement | VATM | Same as above | GCST90016671 | 32,860 | 2021 |
Nonalcoholic fatty liver disease | NAFLD | ICD10 | finngen_R9_NAFLD | 375,000 | 2023 |
Cirrhosis of the liver | NAC | ICD10 | finngen_R9_CHIRHEP_NAS | 373,300 | 2023 |
Hepatocellular carcinoma | HCC | ICD10 | finngen_R9_C3_HEPATOCELLU | 287,137 | 2023 |